Inspire Medical CPO covers taxes with 615 shares

Inspire Medical Systems, Inc. Chief People Officer Melissa Mann reported a Form 4 showing a tax-related share disposition.

Rhea-AI Filing Summary

Inspire Medical Systems, Inc. Chief People Officer Melissa Mann reported a Form 4 showing a tax-related share disposition. The company withheld 615 shares of common stock at $59.76 per share to satisfy taxes due upon vesting of a restricted stock unit award. After this withholding, she directly holds 7,651 common shares.

Insider Trade Summary

Exercise Price or Tax Liability: 615 shares

Exercise Price or Tax Liability 1 txn

Insider Mann Melissa

Role Chief People Officer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	615	$59.76	$37K

Holdings After Transaction: Common Stock — 7,651 shares (Direct)

Footnotes (1)

1. F1. Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a restricted stock unit award.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Inspire Medical Systems (INSP) report?

Inspire Medical Systems reported that Chief People Officer Melissa Mann had 615 common shares withheld. These shares were retained by the company to cover taxes triggered by the vesting of a restricted stock unit award, rather than being sold on the open market.

Who is the insider in this Inspire Medical Systems Form 4 filing?

The insider is Melissa Mann, Chief People Officer of Inspire Medical Systems, Inc. She is an executive officer, not a director or 10% owner, and the reported transaction reflects shares withheld to cover tax obligations from restricted stock unit vesting.

How many Inspire Medical Systems shares were disposed of for taxes?

A total of 615 Inspire Medical Systems common shares were disposed of to satisfy tax liabilities. The shares were withheld by the issuer in connection with the vesting of a restricted stock unit award, according to the Form 4 and its accompanying footnote disclosure.

What price per share was used for the Inspire Medical Systems tax withholding?

The Form 4 shows a price of $59.76 per Inspire Medical Systems common share for the tax-withholding disposition. This price is used solely for reporting the value of the 615 withheld shares tied to the restricted stock unit vesting event.

How many Inspire Medical Systems shares does Melissa Mann own after the transaction?

After the tax-withholding transaction, Melissa Mann directly owns 7,651 shares of Inspire Medical Systems common stock. This figure reflects her remaining holdings following the issuer’s retention of 615 shares to cover taxes from the restricted stock unit vesting.

Was the Inspire Medical Systems insider transaction an open-market sale?

No, the transaction was not an open-market sale. The Form 4 and footnote explain that 615 shares were withheld by Inspire Medical Systems to satisfy tax obligations from a restricted stock unit vesting, a non-market disposition for tax purposes.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/18/2026 - 04:08 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mann Melissa

(Last) (First) (Middle)

C/O INSPIRE MEDICAL SYSTEMS, INC.

5500 WAYZATA BLVD., SUITE 1600

(Street)

GOLDEN VALLEY MN 55416

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Inspire Medical Systems, Inc. [ INSP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief People Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/13/2026		F		615(1)	D	$59.76	7,651	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a restricted stock unit award.

Remarks:

Exhibit 24 - Power of Attorney.

	/s/ Bryan Phillips, Attorney-in-Fact for Melissa Mann	02/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.